A Study Evaluating The Safety, Pharmacokinetics, and Efficacy Of Crovalimab Versus Eculizumab In Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A study designed to evaluate the safety of crovalimab with eculizumab in participants with PNH currently treated with complement inhibitors. This study will enroll approximately 190 participants.
Epistemonikos ID: edef183a2f951458ddd669d871a62c7ac3a430c8
First added on: May 07, 2024